Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 5/2004

01.11.2004 | Original Article

Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats

verfasst von: Ibrahim Yildirim, Ahmet Korkmaz, Sukru Oter, Ayhan Ozcan, Emin Oztas

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to evaluate whether combination of antioxidants and mesna may prevent cystitis induced by cyclophosphamide better than mesna alone.

Materials and methods

A total of 46 male Spraque-Dawley rats were divided into six groups. Five groups received single dose of cyclophosphamide (CP, 100 mg/kg) intraperitoneally with the same time intervals: group 2 received CP only, group 3 received mesna (21.5 mg/kg for three times), group 4 beta-carotene (20 mg/kg for two times) and mesna, group 5 received alpha-tocopherol (20 mg/kg for two times) and mesna, and group 6 received melatonin (5 mg/kg for two times) and mesna on the day of CP injection. Group 1 served as control.

Results

CP injection resulted in severe cystitis. Mesna has showed meaningful but not full protection against CP toxicity. Although beta-carotene did not show any additional beneficial effect when combined with mesna, alpha-tocopherol and especially melatonin with mesna resulted full protection that the pathologist, blinded to the slides, could not differ from sham control.

Conclusion

Oxidants may be important in the pathogenesis of CP-induced cystitis. Melatonin and alpha-tocopherol may help to ameliorate bladder damage along with other drugs such as mesna and diuretics.
Literatur
1.
Zurück zum Zitat Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271C:1424–1437 Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271C:1424–1437
2.
Zurück zum Zitat Brock N, Pohl J, Stekar J (1981) Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. I. Experimental studies on the urotoxicity of alkylating compounds. Eur J Cancer 17(6):595–607CrossRefPubMed Brock N, Pohl J, Stekar J (1981) Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. I. Experimental studies on the urotoxicity of alkylating compounds. Eur J Cancer 17(6):595–607CrossRefPubMed
3.
Zurück zum Zitat Crow JP, Beckman JS (1996) The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. Adv Exp Med Biol 387:147–161PubMed Crow JP, Beckman JS (1996) The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. Adv Exp Med Biol 387:147–161PubMed
4.
Zurück zum Zitat Cuzzocrea S, Reiter RJ (2001) Pharmacological action of melatonin in shock, inflammation, and ischemia/reperfusion injury. Eur J Pharm 426:1–10CrossRef Cuzzocrea S, Reiter RJ (2001) Pharmacological action of melatonin in shock, inflammation, and ischemia/reperfusion injury. Eur J Pharm 426:1–10CrossRef
5.
Zurück zum Zitat Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C (1997) Melatonin is a scavenger of peroxynitrite. Life Sci 60:169–174CrossRef Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C (1997) Melatonin is a scavenger of peroxynitrite. Life Sci 60:169–174CrossRef
6.
Zurück zum Zitat Gilbert CJ, Petros WP, Vredenburgh J, Hussein A, Ross M, Rubin P, Fehdrau R, Cavanaugh C, Berry D, McKinstry C, Peters WP (1998) Pharmacokinetic interaction between ondanstetron and cyclophosphamide during high-dose chemotherapy for breast cancer. Cancer Chemother Pharmacol 42:497–503CrossRefPubMed Gilbert CJ, Petros WP, Vredenburgh J, Hussein A, Ross M, Rubin P, Fehdrau R, Cavanaugh C, Berry D, McKinstry C, Peters WP (1998) Pharmacokinetic interaction between ondanstetron and cyclophosphamide during high-dose chemotherapy for breast cancer. Cancer Chemother Pharmacol 42:497–503CrossRefPubMed
7.
Zurück zum Zitat Goren MP, McKenna LM, Goodman TL (1997) Combined intravenous and oral mesna in outpatients treated with ifosfamide. Cancer Chemother Pharmacol 40:371–375CrossRefPubMed Goren MP, McKenna LM, Goodman TL (1997) Combined intravenous and oral mesna in outpatients treated with ifosfamide. Cancer Chemother Pharmacol 40:371–375CrossRefPubMed
8.
Zurück zum Zitat Gray KJ, Engelmann UH, Johnson EH, Fishman IJ (1986) Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (cytoxan) therapy. J Urol 133:497–500 Gray KJ, Engelmann UH, Johnson EH, Fishman IJ (1986) Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (cytoxan) therapy. J Urol 133:497–500
9.
Zurück zum Zitat Korkmaz A, Oter S, Deveci S, Ozgurtas T, Topal T, Sadir S, Bilgic H (2003) Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 170:2498–2502PubMed Korkmaz A, Oter S, Deveci S, Ozgurtas T, Topal T, Sadir S, Bilgic H (2003) Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 170:2498–2502PubMed
10.
Zurück zum Zitat Kurovski V, Wagner T (1997) Urinary excretion of ifosfamide, 4-hidroxyfosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy. Cancer Chemother Pharmacol 39:431–439CrossRefPubMed Kurovski V, Wagner T (1997) Urinary excretion of ifosfamide, 4-hidroxyfosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy. Cancer Chemother Pharmacol 39:431–439CrossRefPubMed
11.
Zurück zum Zitat Maharaj DS, Anoopkumar-Dukie S, Glass BD, Antunes EM, Lack B, Walker RB, Daya S (2002) The identification of the UV degradants of melatonin and their ability to scavenge radicals. J Pineal Res 32:257–261CrossRefPubMed Maharaj DS, Anoopkumar-Dukie S, Glass BD, Antunes EM, Lack B, Walker RB, Daya S (2002) The identification of the UV degradants of melatonin and their ability to scavenge radicals. J Pineal Res 32:257–261CrossRefPubMed
12.
Zurück zum Zitat Mates JM, Perez-Gomez P, Nunez de Castro I (1999) Antioxidant enzymes and human disease. Clin Biochem 32:595–603CrossRefPubMed Mates JM, Perez-Gomez P, Nunez de Castro I (1999) Antioxidant enzymes and human disease. Clin Biochem 32:595–603CrossRefPubMed
13.
Zurück zum Zitat Muijsers RB, Folkerts G, Henricks PAJ, Hashjin GS, Nijkamp FP (1997) Peroxynitrite: a two faced metabolite of nitric oxide. Life Sci 60:1833–1845CrossRefPubMed Muijsers RB, Folkerts G, Henricks PAJ, Hashjin GS, Nijkamp FP (1997) Peroxynitrite: a two faced metabolite of nitric oxide. Life Sci 60:1833–1845CrossRefPubMed
14.
Zurück zum Zitat Olson JA (1993) Molecular actions of carotenoids. Ann N Y Acad Sci 691:156–166PubMed Olson JA (1993) Molecular actions of carotenoids. Ann N Y Acad Sci 691:156–166PubMed
15.
Zurück zum Zitat Oter S, Korkmaz A, Oztas E, Yildirim I, Topal T, Bilgic H (2004) Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats. Urol Res 32:185–189CrossRefPubMed Oter S, Korkmaz A, Oztas E, Yildirim I, Topal T, Bilgic H (2004) Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats. Urol Res 32:185–189CrossRefPubMed
16.
Zurück zum Zitat Ribeiro RA, Feritas HC, Campos MC, Santos CC, Figueiredo FC, Brito GA, Cunha FQ (2002) Tumor necrosis factor-α and interleukin-1β mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol 67(5):2229–2234CrossRef Ribeiro RA, Feritas HC, Campos MC, Santos CC, Figueiredo FC, Brito GA, Cunha FQ (2002) Tumor necrosis factor-α and interleukin-1β mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol 67(5):2229–2234CrossRef
17.
Zurück zum Zitat Szabo C (1996) The pathophysiological role of role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6:79–88PubMed Szabo C (1996) The pathophysiological role of role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6:79–88PubMed
18.
Zurück zum Zitat Virag L, Szabo E, Gergely P, Szabo C (2003) Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 141:113–124CrossRef Virag L, Szabo E, Gergely P, Szabo C (2003) Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 141:113–124CrossRef
19.
Zurück zum Zitat West NJ (1997) Prevention and treatment of hemorrhagic cystitis. Pharmacotherapy 17(4):696–706PubMed West NJ (1997) Prevention and treatment of hemorrhagic cystitis. Pharmacotherapy 17(4):696–706PubMed
Metadaten
Titel
Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats
verfasst von
Ibrahim Yildirim
Ahmet Korkmaz
Sukru Oter
Ayhan Ozcan
Emin Oztas
Publikationsdatum
01.11.2004
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 5/2004
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-004-0822-1

Weitere Artikel der Ausgabe 5/2004

Cancer Chemotherapy and Pharmacology 5/2004 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.